Abstract
The biological roles of nitric oxide (NO) and cGMP as inter- and intracellular messengers have been intensively investigated during the last decade. NO and cGMP both mediate physiological effects in the cardiovascular, endocrinological, and immunological systems as well as in central nervous system (CNS). In the CNS, activation of theN-methyl-d-aspartic acid (NMDA) type of glutamatergic receptor induces Ca2+-dependent NOS and NO release, which then activates soluble guanylate cyclase for the synthesis of cGMP.
Both compounds appear to be important mediators in long-term potentiation and long-term depression, and thus may play important roles in the mechanisms of learning and memory. Aging and the accumulation of amyloid β (Aβ) peptides are important risk factors for the impairment of memory and development of dementia. In these studies, the mechanism of basal- and NMDA receptor-mediated cGMP formation in different parts of adult and aged brains was evaluated. The relative activity of the NO cascade was determined by assay of NOS and guanylate cyclase activities. In addition, the effect of the neurotoxic fragment 25–35 of Aβ (Aβ) peptide on basal and NMDA receptor-mediated NOS activity was investigated. The studies were carried out using slices of hippocampus, brain cortex, and cerebellum from 3- and 28-mo-old rats.
Aging coincided with a decrease in the basal level of cGMP as a consequence of a more active degradation of cGMP by a phosphodiesterase in the aged brain as compared to the adult brain. Moreover, a loss of the NMDA receptor-stimulated enhancement of the cGMP level determined in the presence of cGMP-phosphodiesterase inhibitor 3-isobutyl-1-methylxanthine (IBMX) was observed in hippocampus and cerebellum of aged rats. However, this NMDA receptor response was preserved in aged brain cerebral cortex. A significant enhancement of the basal activity of NOS by about 175 and 160% in hippocampus and cerebellum, respectively, of aged brain may be involved in the alteration of the NMDA receptor response. The neurotoxic fragment of Aβ, peptide 25–35, decreased significantly the NMDA receptor-mediated calcium, and calmodulin-dependent NO synthesis that may then be responsible for disturbances of the NO and cGMP signaling pathway.
We concluded that cGMP-dependent signal transduction in hippocampus and cerebellum may become insufficient in senescent brain and may have functional consequences in disturbances of learning and memory processes. Aβ peptide accumulated during brain aging and in Alzheimer disease may be an important factor in decreasing the NO-dependent signal transduction mediated by NMDA receptors.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Abbreviations
- Aβ:
-
β-amyloid peptide
- CNS:
-
central nervous system
- NMDA:
-
N-methyl-d-aspartic acid
- APP:
-
β-amyloid precursor proteins
- NOS:
-
nitric oxide synthese
- NO:
-
nitric oxide
References
Antoni F. A. and Dayanithi G. (1990) Blockage of K+ channels reverses the inhibitory action of atriopeptin on secretagogue-stimulated ACTH release by perifused isolated rat anterior pituitary cells.J. Endocrinol. 126, 183–191.
Barger S. W., Fiscus R. R., Ruth P., Hofmann F., and Mattson M. P. (1995) Role of cyclic GMP in the regulation of neuronal calcium and survival by secreted forms of β-amyloid precursor.J. Neurochem. 64, 2087–2096.
Bernabeu R., Schroder N., Quevedo J., Cammarota M., Izquierdo I., and Medina J. H. (1997) Further evidence for the involvement of a hippocampal cGMP/cGMP-dependent protein kinase cascade in memory consolidation.NeuroReport 8, 2221–2224.
Bonkale W. L., Winblad B., Ravid R., and Cowburn R. F. (1995) Reduced nitric oxide responsive soluble guanylyl cyclase activity in the superior temporal cortex of patients with Alzheimer’s disease.Neurosci. Lett. 187, 5–8.
Bredt D. S. and Snyder S. H. (1990) Isolation of nitric oxide synthetase, a calmodulinrequiring enzyme.Proc. Natl. Acad. Sci. USA 87, 682–685.
Brown J. and Czarnecki A. (1990) Autoradiographic localization of atrial and brain natriuretic peptide receptors in rat brain.Am. J. Physiol. 258, R57-R63.
Buisson A., Lakhmeche N., Verrecchia C., Plotkine M., and Boulu R. G. (1993) Nitric oxide: an endogenous anticonvulsant substance.NeuroReport 4, 444–446.
Chalimoniuk M. and Strosznajder J. (1997) Aging decreases the basal level of cGMP and eliminates NMDA receptor dependent cGMP formation in hippocampus and cerebellum; effect of amyloid β.J. Neurochem. 69 Suppl., S180B-S180B (Abstract).
Collingridge G. L. and Singer W. (1990) Excitatory amino acid receptors and synaptic plasticity.Trends Pharmacol. Sci. 11, 290–296.
Constantine-Paton M., Cline H. T., and Debski E. (1990) Patterned activity, synaptic convergence, and the NMDA receptor in developing visual pathways.Annu. Rev. Neurosci. 13, 129–154.
Deguchi T. (1977) Endogenous activating factor for guanylate cyclase in synaptosomalsoluble fraction of rat brain.J. Biol. Chem. 252, 7617–7619.
Deguchi T. and Yoshioka M. (1982)l-Arginine identified as an endogenous activator for soluble guanylate cyclase from neuroblastoma cells.J. Biol. Chem. 257, 10,147–10,151.
Doerner D. and Alger B. E. (1988) Cyclic GMP depresses hippocampal Ca2+ current through a mechanism independent of cGMP-dependent protein kinase.Neuron 1, 693–699.
Fiez J. A. (1996) Cerebellar contributions to cognition.Neuron 16, 13–15.
Forstermann U., Schmidt H. H., Pollock J. S., Sheng H., Mitchell J. A., Warner T. D., et al. (1991) Isoforms of nitric oxide synthase. Characterization and purification from different cell types.Biochem. Pharmacol. 42, 1849–1857.
Furukawa K., Barger S. W., Blalock E. M., and Mattson M. P. (1996) Activation of K+ channels and suppression of neuronal activity by secreted β-amyloid-precursor protein.Nature 379, 74–78.
Gally J. A., Montague P. R., Reeke G. N. Jr., and Edelman G. M. (1990) The NO hypothesis: Possible effects of a short-lived, rapidly diffusible signal in the development and function of the nervous system.Proc. Natl. Acad. Sci. USA 87, 3547–3551.
Garthwaite J. (1991) Glutamate, nitric oxide and cell-cell signalling in the nervous system.Trends Neurosci. 14, 60–67.
Garthwaite J. and Boulton C. L. (1995) Nitric oxide signaling in the central nervous system.Annu. Rev. Physiol. 57, 683–706.
Garthwaite G. and Garthwaite J. (1988) Cyclic GMP and cell death in rat cerebellar slices.Neuroscience 26, 321–326.
Garthwaite J., Charles S. L., and Chess-Williams R. (1988) Endothelium-derived relaxing factor release on activation of NMDA receptors suggests role as intercellular messenger in the brain.Nature 336, 385–388.
Hirata M., Kohse K. P., Chang C. H., Ikebe T., and Murad F. (1990) Mechanism of cyclic GMP inhibition of inositol phosphate formation in rat aorta segments and cultured bovine aortic smooth muscle cells.J. Biol. Chem. 265, 1268–1273.
Hosli E. and Hosli L. (1992) Autoradiographic localization of binding sites for arginine vasopressin and atrial natriuretic peptide on astrocytes and neurons of cultured rat central nervous system.Neuroscience 51, 159–166.
Hu J. and El-Fakahany E. E. (1993) Role of intercellular and intracellular communication by nitric oxide in coupling of muscarinic receptors to activation of guanylate cyclase in neuronal cells.J. Neurochem. 61, 578–585.
Johnston H. M. and Morris B. J. (1994) NMDA and nitric oxide increase microtubule-associated protein 2 gene expression in hippocampal granule cells.J. Neurochem. 63, 379–382.
Knowles R. G., Palacios M., Palmer R. M., and Moncada S. (1989) Formation of nitric oxide froml-arginine in the central nervous system: a transduction mechanism for stimulation of the soluble guanylate cyclase.Proc. Natl. Acad. Sci. USA 86, 5159–5162.
Luscher T. F., Tanner F. C., and Dohi Y. (1992) Age, hypertension and hypercholesterolaemia alter endothelium-dependent vascular regulation.Pharmacol. Toxicol. 70, S32-S39.
Malenka R. C. (1994) Synaptic plasticity in the hippocampus: LTP and LTD.Cell 78, 535–538.
Manzoni O., Prezeau L., Marin P., Deshager S., Bockaert J., and Fagni L. (1992) Nitric oxide-induced blockade of NMDA receptors.Neuron 8, 653–662.
Meriney S. D., Gray D. B., and Pilar G. R. (1994) Somatostatin-induced inhibition of neuronal Ca2+ current modulated by cGMP-dependent protein kinase [published erratum appears inNature Oct 27, 1994;371(6500):812].Nature 369, 336–339.
Mery P. F., Lohmann S. M., Walter U., and Fischmeister R. (1991) Ca2+ current is regulated by cyclic GMP-dependent protein kinase in mammalian cardiac myocytes.Proc. Natl. Acad. Sci. USA 88, 1197–1201.
Miki N., Kawabe Y., and Kuriyama K. (1977) Activation of cerebral guanylate cyclase by nitric oxide.Biochem. Biophys. Res. Commun. 75, 851–856.
Monaghan D. T., Bridges R. J., and Cotman C. W. (1989) The excitatory amino acid receptors: Their classes, pharmacology, and distinct properties in the function of the central nervous system.Annu. Rev. Pharmacol. Toxicol. 29, 365–402.
Schamahmana J. D. (1994)Neurobiology of Autism (Bauman M. L. and Kemper T. L., eds.), pp. 195–226, Johns Hopkins University Press, Baltimore.
Shibuki K. and Okada D. (1991) Endogenous nitric oxide release required for long-term synaptic depression in the cerebellum.Nature 349, 326–328.
Tamaru M., Yoneda Y., Ogita K., Shimizu J., and Nagata Y. (1991) Age-related decreases of theN-methyl-d-aspartate receptor complex in the rat cerebral cortex and hippocampus.Brain Res. 542, 83–90.
Vincent T. (1995)Nitric Oxide in the Nervous System, Academic Press, London.
Wahler G. M., Rusch N. J., and Sperelakis N. (1990) 8-Bromo-cyclic GMP inhibits the calcium channel current in embryonic chick ventricular myocytes.Can. J. Physiol. Pharmacol. 68, 531–534.
Wang X. and Robinson P. J. (1997) Cyclic GMP-dependent protein kinase and cellular signaling in the nervous system.J. Neurochem. 68, 443–456.
White R. E., Lee A. B., Shcherbatko A. D., Lincoln T. M., Schonbrunn A., and Armstrong D. L. (1993) Potassium channel stimulation by natriuretic peptides through cGMP-dependent dephosphorylation.Nature 361, 263–266.
Zhuo M., Hu Y., Schultz C., Kandel E. R., and Hawkins R. D. (1994) Role of guanylyl cyclase and cGMP-dependent protein kinase in long-term potentiation.Nature 368, 635–639.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Chalimoniuk, M., Strosznajder, J.B. Aging modulates nitric oxide synthesis and cGMP levels in hippocampus and cerebellum. Molecular and Chemical Neuropathology 35, 77–95 (1998). https://doi.org/10.1007/BF02815117
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02815117